Literature DB >> 35861660

S-Palmitoylation and Sterol Interactions Mediate Antiviral Specificity of IFITMs.

Tandrila Das1,2,3, Xinglin Yang3, Hwayoung Lee4, Emma H Garst1,2, Estefania Valencia5, Kartik Chandran5, Wonpil Im4, Howard C Hang3,6.   

Abstract

Interferon-induced transmembrane proteins (IFITM1, 2, and 3) are important antiviral proteins that are active against many viruses, including influenza A virus (IAV), dengue virus (DENV), Ebola virus (EBOV), Zika virus (ZIKV), and severe acute respiratory syndrome coronavirus (SARS-CoV). IFITM proteins exhibit specificity in activity, but their distinct mechanisms of action and regulation are unclear. Since S-palmitoylation and cholesterol homeostasis are crucial for viral infections, we investigated IFITM interactions with cholesterol by photoaffinity cross-linking in mammalian cells along with molecular dynamic simulations and nuclear magnetic resonance analysis in vitro. These studies suggest that cholesterol can directly interact with S-palmitoylated IFITMs in cells and alter the conformation of IFITMs in membrane bilayers. Notably, we discovered that the S-palmitoylation levels regulate differential IFITM protein interactions with cholesterol in mammalian cells and specificity of antiviral activity toward IAV, SARS-CoV-2, and EBOV. Our studies suggest that modulation of IFITM S-palmitoylation levels and cholesterol interaction influence host susceptibility to different viruses.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35861660     DOI: 10.1021/acschembio.2c00176

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   4.634


  2 in total

1.  Identification of potential modulators of IFITM3 by in-silico modeling and virtual screening.

Authors:  Vikas Tiwari; Shruthi Viswanath
Journal:  Sci Rep       Date:  2022-09-24       Impact factor: 4.996

2.  Revealing the characteristics of ZIKV infection through tissue-specific transcriptome sequencing analysis.

Authors:  Zhi-Lu Chen; Zuo-Jing Yin; Tian-Yi Qiu; Jian Chen; Jian Liu; Xiao-Yan Zhang; Jian-Qing Xu
Journal:  BMC Genomics       Date:  2022-10-08       Impact factor: 4.547

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.